IFNL3 and metabolic dysfunction-associated steatohepatitis: Elevated IFN-λ3 production has demonstrated a strong association with IFNL genotype and hepatic inflammation, increasing the risk of both viral (HBV and HCV) and non-viral (non-alcoholic steatohepatitis, NASH) related progressive liver inflammation and fibrosis (4).